We are enclosing herewith the Press Release on receipt of order from one of India''s leading chain of pharmacy for manufacturing and supply of Hair Care products.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Veerhealth Care has received an order worth around ₹0.49 crores from one of India's leading pharmacy chains (5,000+ retail outlets) for manufacturing and supply of hair care products, to be executed within 45 days. The company also highlighted its earlier USFDA plant clearance, ongoing discussions with a Russian corporate group for oral care exports, and the launch of a new hospital care division for medical equipment. Management reiterated FY25-26 revenue guidance of ₹35-40 crores with 10% PAT margin, and a longer-term target of ₹100 crores revenue with 10% PAT within 24-36 months. Repeat orders from this client are expected.
The order value (~₹0.49 crores) is small relative to expected FY25-26 revenue of ₹35-40 crores, so direct revenue impact is limited, but it strengthens the company's client portfolio and credibility. Shareholders should watch for actual export wins and execution against the ₹35-40 crores revenue guidance.